Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kolditz

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 13, 2020
Validation of the qSOFA score compared to the CRB-65 score for risk prediction in community-acquired pneumoniaMiriam Kesselmeier, Mathias W Pletz, Anna Leona Blankenstein, et al.
BMC Infectious Diseases|April 17, 2012
Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort studyMartin Kolditz, Gert Höffken, Peter Martus, et al.
ERJ Open Research|October 22, 2025
Performance of risk prediction scores for severe pneumonia in patients with community-acquired pneumonia after organ transplantationJessica Rademacher, Laura von Eynern, Sabine Dettmer, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 27, 2023
Long-COVID is Associated with Impaired Red Blood Cell FunctionRomy Kronstein-Wiedemann, Kristin Tausche, Martin Kolditz, et al.
Thorax|March 19, 2015
Community-acquired pneumonia as medical emergency: predictors of early deteriorationMartin Kolditz, Santiago Ewig, Benjamin Klapdor, et al.
GMS Infectious Diseases|May 7, 2020
Calculated parenteral initial treatment of bacterial infections: Respiratory infectionsSebastian R Ott, Klaus-Friedrich Bodmann, Béatrice Grabein, et al.
The European Respiratory Journal|September 21, 2019
Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learningRainer König, Xueqi Cao, Marcus Oswald, et al.
Viruses|November 27, 2025
Clinical Outcomes of COPD Patients Hospitalized for SARS-Cov-2 Infection During the Omicron Era: Comparative Effectiveness of Initiating Remdesivir in Addition to Corticosteroids Versus Corticosteroids AloneNeera Ahuja, Heng Jiang, Marc Milano, et al.
The European Respiratory Journal|November 26, 2021
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in GermanyChristina Bahrs, Miriam Kesselmeier, Martin Kolditz, et al.
Vaccine|November 26, 2019
Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumoniaChristina Forstner, Martin Kolditz, Miriam Kesselmeier, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 13, 2020
Validation of the qSOFA score compared to the CRB-65 score for risk prediction in community-acquired pneumoniaMiriam Kesselmeier, Mathias W Pletz, Anna Leona Blankenstein, et al.
BMC Infectious Diseases|April 17, 2012
Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort studyMartin Kolditz, Gert Höffken, Peter Martus, et al.
ERJ Open Research|October 22, 2025
Performance of risk prediction scores for severe pneumonia in patients with community-acquired pneumonia after organ transplantationJessica Rademacher, Laura von Eynern, Sabine Dettmer, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 27, 2023
Long-COVID is Associated with Impaired Red Blood Cell FunctionRomy Kronstein-Wiedemann, Kristin Tausche, Martin Kolditz, et al.
Thorax|March 19, 2015
Community-acquired pneumonia as medical emergency: predictors of early deteriorationMartin Kolditz, Santiago Ewig, Benjamin Klapdor, et al.
GMS Infectious Diseases|May 7, 2020
Calculated parenteral initial treatment of bacterial infections: Respiratory infectionsSebastian R Ott, Klaus-Friedrich Bodmann, Béatrice Grabein, et al.
The European Respiratory Journal|September 21, 2019
Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learningRainer König, Xueqi Cao, Marcus Oswald, et al.
Viruses|November 27, 2025
Clinical Outcomes of COPD Patients Hospitalized for SARS-Cov-2 Infection During the Omicron Era: Comparative Effectiveness of Initiating Remdesivir in Addition to Corticosteroids Versus Corticosteroids AloneNeera Ahuja, Heng Jiang, Marc Milano, et al.
The European Respiratory Journal|November 26, 2021
A longitudinal analysis of pneumococcal vaccine serotypes in pneumonia patients in GermanyChristina Bahrs, Miriam Kesselmeier, Martin Kolditz, et al.
Vaccine|November 26, 2019
Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumoniaChristina Forstner, Martin Kolditz, Miriam Kesselmeier, et al.
Pageof 7